(Q37700356)

22 August 2017

1 reference

title

Better understanding tumor-host interaction in head and neck cancer to improve the design and development of immunotherapeutic strategies (English)

1 reference

22 August 2017

1 reference

1 reference

1 reference

head and neck carcinoma

1 reference

12

Eric Tartour

0 references

Wolf Hervé Fridman

11

object named as

Wolf H Fridman

0 references

Patrick Bruneval

9

object named as

Patrick Bruneval

1 reference

22 August 2017

Cécile Badoual

1

1 reference

22 August 2017

Federico Sandoval

2

1 reference

22 August 2017

Helene Pere

3

1 reference

22 August 2017

Stephane Hans

4

1 reference

22 August 2017

Alain Gey

5

1 reference

22 August 2017

Nathalie Merillon

6

1 reference

22 August 2017

Cordelia Van Ryswick

7

1 reference

22 August 2017

Françoise Quintin-Colonna

8

1 reference

22 August 2017

Daniel Brasnu

10

1 reference

22 August 2017

publication date

1 July 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

32

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

946-958

1 reference

A human CTL recognizes a caspase-8-derived peptide on autologous HLA-B*3503 molecules and two unrelated peptides on allogeneic HLA-B*3501 molecules

22 August 2017

cites work

1 reference

Generation of T cells specific for the wild-type sequence p53(264-272) peptide in cancer patients: implications for immunoselection of epitope loss variants

21 January 2018

1 reference

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma

21 January 2018

1 reference

Restoration by IL-15 of MHC class I antigen-processing machinery in human dendritic cells inhibited by tumor-derived gangliosides

21 January 2018

1 reference

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

Human tumor-derived exosomes down-modulate NKG2D expression.

21 January 2018

1 reference

Antitumor and antimetastatic activity of IL-23

21 January 2018

1 reference

IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells

21 January 2018

1 reference

Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions

21 January 2018

1 reference

Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells

21 January 2018

1 reference

Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma

21 January 2018

1 reference

Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck: a phase 1 study

21 January 2018

1 reference

A mouse model of human oral-esophageal cancer

21 January 2018

1 reference

B subunit of Shiga toxin-based vaccines synergize with alpha-galactosylceramide to break tolerance against self antigen and elicit antiviral immunity.

21 January 2018

1 reference

Increased Prevalence of Dysplastic and Malignant Lip Lesions in Renal-Transplant Recipients

21 January 2018

1 reference

7 January 2021

Solid cancers after bone marrow transplantation

1 reference

7 January 2021

Oral malignancies following HSCT: graft versus host disease and other risk factors.

1 reference

7 January 2021

Comparison of HPV infection, p53 mutation and allelic losses in post-transplant and non-posttransplant oral squamous cell carcinomas.

1 reference

7 January 2021

Squamous cell carcinoma of the tongue after bone marrow transplant and graft-versus-host disease: a case report and review of the literature

1 reference

7 January 2021

Quantitative expression and immunogenicity of MAGE-3 and -6 in upper aerodigestive tract cancer.

1 reference

7 January 2021

Cancer immunotherapy targeting tumour-specific antigens: towards a new therapy for minimal residual disease

1 reference

7 January 2021

Alteration of Cellular and Humoral Immunity by Mutant p53 Protein and Processed Mutant Peptide in Head and Neck Cancer

1 reference

7 January 2021

Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.

1 reference

7 January 2021

T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx

1 reference

7 January 2021

Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients

1 reference

7 January 2021

Human T cell responses against melanoma

1 reference

7 January 2021

Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer

1 reference

7 January 2021

HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.

1 reference

7 January 2021

Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.

1 reference

7 January 2021

Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR.

1 reference

7 January 2021

Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy

1 reference

7 January 2021

Variable expression of CD3-ζ chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: Relationship with til phenotype and function

1 reference

7 January 2021

Tumor-induced immune dysfunction

1 reference

7 January 2021

The tumor microenvironment and its role in promoting tumor growth

1 reference

7 January 2021

Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer

1 reference

7 January 2021

Galectin-1: a link between tumor hypoxia and tumor immune privilege

1 reference

7 January 2021

Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege

1 reference

7 January 2021

Galectins as modulators of tumor progression in head and neck squamous cell carcinomas

1 reference

7 January 2021

Presence of membrane-bound TGF-beta1 and its regulation by IL-2-activated immune cell-derived IFN-gamma in head and neck squamous cell carcinoma cell lines

1 reference

7 January 2021

A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment

1 reference

7 January 2021

The Hallmarks of Cancer

1 reference

7 January 2021

Friends or foes - bipolar effects of the tumour stroma in cancer

1 reference

7 January 2021

1 reference

7 January 2021

Cytokine-based transformation of immune surveillance into tumor-promoting inflammation

1 reference

7 January 2021

A cytokine-mediated link between innate immunity, inflammation, and cancer

1 reference

7 January 2021

Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer

1 reference

7 January 2021

The effect of tetrathiomolybdate on cytokine expression, angiogenesis, and tumor growth in squamous cell carcinoma of the head and neck

1 reference

7 January 2021

Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-alpha, to induce apoptosis in Jurkat T cells: possible mechanisms for immune escape by head and neck cancers.

1 reference

7 January 2021

Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines

1 reference

7 January 2021

Interleukin-6 predicts recurrence and survival among head and neck cancer patients

1 reference

7 January 2021

Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

1 reference

7 January 2021

Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma: results of a multivariate prospective study

1 reference

7 January 2021

Serum soluble interleukin–2 receptor concentrations as an independent prognostic marker in head and neck cancer

1 reference

7 January 2021

Cell-mediated immunity and head and neck cancer: with special emphasis on betel quid chewing habit

1 reference

7 January 2021

Genetic association of cytokine DNA polymorphisms with head and neck cancer

1 reference

7 January 2021

Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships

1 reference

7 January 2021

Regulation and function of NF-kappaB transcription factors in the immune system

1 reference

7 January 2021

Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2.

1 reference

7 January 2021

Interleukin-17 promotes angiogenesis and tumor growth

1 reference

7 January 2021

Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma

1 reference

7 January 2021

The Soluble Chain of Interleukin-15 Receptor: A Proinflammatory Molecule Associated with Tumor Progression in Head and Neck Cancer

1 reference

7 January 2021

Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.

1 reference

7 January 2021

IL-23 promotes tumour incidence and growth

1 reference

7 January 2021

Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer

1 reference

7 January 2021

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

7 January 2021

CD4+ CD25+ suppressor T cells: more questions than answers

1 reference

7 January 2021

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

7 January 2021

Tuning microenvironments: induction of regulatory T cells by dendritic cells

1 reference

7 January 2021

Natural regulatory T cells: mechanisms of suppression

1 reference

7 January 2021

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

7 January 2021

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

1 reference

7 January 2021

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

7 January 2021

Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

1 reference

7 January 2021

FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.

1 reference

7 January 2021

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

1 reference

7 January 2021

Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer

1 reference

7 January 2021

Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck

1 reference

7 January 2021

Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites

1 reference

7 January 2021

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

1 reference

7 January 2021

The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck

1 reference

7 January 2021

Prognostic value of CD25 expression on lymphocytes and tumor cells in squamous-cell carcinoma of the head and neck.

1 reference

7 January 2021

Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome

1 reference

7 January 2021

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells

1 reference

7 January 2021

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

1 reference

7 January 2021

CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice.

1 reference

7 January 2021

Revisiting the Prognostic Value of Regulatory T Cells in Patients With Cancer

1 reference

7 January 2021

T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis

1 reference

7 January 2021

Molecular antagonism and plasticity of regulatory and inflammatory T cell programs

1 reference

7 January 2021

Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma

1 reference

7 January 2021

Role of immature myeloid cells in mechanisms of immune evasion in cancer

1 reference

7 January 2021

Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells

1 reference

7 January 2021

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

1 reference

7 January 2021

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

1 reference

7 January 2021

Multipotency of CD11bhighGr-1+ immature myeloid cells accumulating in oral squamous cell carcinoma-bearing mice

1 reference

7 January 2021

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo.

1 reference

7 January 2021

Expression of basic fibroblast growth factor protein and its down-regulation by interferons in head and neck cancer

1 reference

7 January 2021

Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways

1 reference

7 January 2021

Swords into plowshares: IL-23 repurposes tumor immune surveillance

1 reference

7 January 2021

Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals

1 reference

7 January 2021

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

1 reference

7 January 2021

Development, cytokine profile and function of human interleukin 17-producing helper T cells

1 reference

7 January 2021

Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome).

1 reference

7 January 2021

Activation of Stat-3 as one of the early events in tobacco chewing-mediated oral carcinogenesis

1 reference

7 January 2021

Role of Stat3 in suppressing anti-tumor immunity

1 reference

7 January 2021

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma

1 reference

7 January 2021

Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer

1 reference

7 January 2021

Maintenance immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

7 January 2021

Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2

1 reference

7 January 2021

Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck

1 reference

7 January 2021

Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system

1 reference

7 January 2021

Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cells

1 reference

7 January 2021

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

1 reference

7 January 2021

Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer

1 reference

7 January 2021

Cycloxygenase-2 inhibition augments the efficacy of a cancer vaccine

1 reference

7 January 2021

Impaired monocyte function in cancer patients: restoration with a cyclooxygenase-2 inhibitor

1 reference

7 January 2021

Administration of a prostaglandin synthetase inhibitor associated with an increased immune cell infiltrate in squamous cell carcinoma of the head and neck

1 reference

7 January 2021

A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck

1 reference

7 January 2021

Neoadjuvant immunotherapy of oral squamous cell carcinoma modulates intratumoral CD4/CD8 ratio and tumor microenvironment: a multicenter phase II clinical trial

1 reference

7 January 2021

Targeting angiogenesis in head and neck cancer

1 reference

7 January 2021

Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy

1 reference

7 January 2021

Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients

1 reference

7 January 2021

Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients

1 reference

7 January 2021

Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses

1 reference

7 January 2021

The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies

1 reference

7 January 2021

Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells

1 reference

7 January 2021

A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism

1 reference

7 January 2021

Immunotherapy for head and neck cancer

1 reference

7 January 2021

Vaccine-based approaches to squamous cell carcinoma of the head and neck.

1 reference

7 January 2021

The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity.

1 reference

7 January 2021

Optimizing systemic therapy in squamous cell carcinoma of the head and neck with a focus on targeted agents

1 reference

7 January 2021

Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cells

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.21346

1 reference

22 August 2017

1 reference